MANILA — While the Department of Health awaits official word from the World Health Organization regarding AstraZeneca’s vaccine viability, the agency has to temporarily suspend administration of the vaccine to individuals below 60.
DOH Undersecretary Maria Rosario Vergeire says the suspension is a “precautionary measure” as reports received from the Global Health Referral Network pertained to adverse events of the AstraZeneca vaccine.
“We want to clarify that this is a temporary suspension. Maybe it’s just going to last for about two weeks for us to have all these recommendations,” Vergeire explains during an online briefing.
The Food and Drug Administration has ordered last Thursday the suspension of AstraZeneca for individuals aged 60 and below as there had been reports of blood clotting incidents among Europeans.
Vergeire assures those who already received their first shot of AstraZeneca vaccines to not worry as there had been no similar adverse events in the country.
Meanwhile, the shipment of the second tranche of AstraZeneca jabs from the COVAX Facility is expected to arrive by the end of May or early June. (JSM/JuanManila)